As of June 2024 Avita Medical has a market cap of $0.20 Billion. This makes Avita Medical the world's 6945th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.20 B | -40.83% |
2023 | $0.35 B | 112.2% |
2022 | $0.16 B | -44.67% |
2021 | $0.29 B | -25.68% |
2020 | $0.40 B | -91.66% |
2019 | $4.81 B | 941.17% |
2018 | $0.46 B | 64.51% |
2017 | $0.28 B | -18.86% |
2016 | $0.34 B | 55.18% |
2015 | $0.22 B | 95.47% |
2014 | $0.11 B | -51.5% |
2013 | $0.23 B | 2.4% |
2012 | $0.23 B | 675.3% |
2011 | $29.67 M | |
2008 | $2.35 M | -76.65% |
2007 | $10.07 M | |
2004 | $55.98 M | 29.47% |
2003 | $43.24 M |
On Jun 16th, 2024 the market cap of Avita Medical was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Organovo ONVO | $13.07 M | -93.70% | ๐บ๐ธ USA |
![]() Orchard Therapeutics
ORTX | $0.38 B | 83.25% | ๐ฌ๐ง UK |
![]() Novavax NVAX | $2.11 B | 917.61% | ๐บ๐ธ USA |
![]() Novocure
NVCR | $2.05 B | 888.80% | Jersey |